Biomedical Engineering Reference
In-Depth Information
M, Kuhn W.
17
O-
1
H magnetic resonance
imaging in plants, animals, and materials.
In: Baillie TA, Jones JR, editors. Synthe-
sis and Application of Isotopically Labeled
Compounds.
onance imaging: Part 1. Theory and data
analysis methods. Neurol Res 1992;14(4):
303-311.
80. Fiat D, Dolinsek J, Hankiewicz J, Dujovny
M, Ausman J. Determination of regional
cerebral oxygen consumption in the human:
17
O natural abundance cerebral mag-
netic resonance imaging and spectroscopy
in
Amsterdam:
Elsevier;
1989.
p 499-508.
70. Hopkins AL, Barr RG. Oxygen-17 com-
pounds as potential NMR T
2
contrast agents:
Enrichment effects of H
2
17
O on protein
solutions and living tissues. Magn Reson
Med 1987;4(4):399-403.
71. Kwong KK, Hopkins AL, Belliveau JW,
Chesler DA, Porkka LM, McKinstry RC,
Finelli DA, Hunter GJ, Moore JB, Barr RG,
Rosen BR. Proton NMR imaging of cerebral
blood flow using H
2
17
O. Magn Reson Med
1991;22(1):154-158.
72. Arai T, Nakao S, Mori K, Ishimori K,
Morishima I, Miyazawa T, Fritz-Zieroth B.
Cerebral oxygen utilization analyzed by the
use of oxygen-17 and its nuclear magnetic
resonance. Biochem Biophys Res Commun
1990;169(1):153-158.
73. Pekar J, Sinnwell T, Ligeti L, Chesnick AS,
Frank JA, McLaughlin AC. Simultaneous
measurement of cerebral oxygen consump-
tion and blood flow using
17
Oand
19
Fmag-
netic resonance imaging. J Cereb Blood Flow
Metab 1995;15(2):312-320.
74. Ronen I, Navon G. A new method for proton
detection of H
2
17
O with potential applica-
tions for functional MRI. Magn Reson Med
1994;32(6):789-793.
75. Ronen I, Merkle H, Ugurbil K, Navon
G. Imaging of H
2
17
O distribution in the
brain of a live rat by using proton-detected
17
O
a
whole
body
system.
Neurol
Res
1993;15(4):237-248.
81. Fiat D, Kang S. Determination of the rate
of cerebral oxygen consumption and regional
cerebral blood flow by non-invasive
17
Oin
vivo NMR spectroscopy and magnetic res-
onance imaging. Part 2. Determination of
CMRO
2
for the rat by
17
O NMR, and
CMRO
2
, rCBF and the partition coefficient
for the cat by
17
O MRI. Neurol Res 1993;
15(1):7-22.
82. Mateescu GD. Functional oxygen-17 mag-
netic resonance imaging and localized spec-
troscopy.
Adv
Exp
Med
Biol
2003;510:
213-218.
83. Stolpen AH, Reddy R, Leigh JS.
17
O-
decoupled proton MR spectroscopy and
imaging in a tissue model. J Magn Reson
1997;125(1):1-7.
84. Reddy R, Stolpen AH, Charagundla SR,
Insko EK, Leigh JS.
17
O-decoupled 1H
detection using a double-tuned coil. Magn
Reson Imaging 1996;14(9):1073-1078.
85. de Crespigny AJ, D'Arceuil HE, Engel-
horn T, Moseley ME. MRI of focal cere-
bral ischemia using
17
O-labeled water. Magn
Reson Med 2000;43(6):876-883.
86. Zhu XH, Zhang Y, Zhang N, Ugur-
bil K, Chen W. Noninvasive and three-
dimensional imaging of CMRO
2
in rats at
9.4 T: Reproducibility test and normother-
mia/hypothermia comparison study. J Cereb
Blood Flow Metab 2007;27(6):1225-1234.
87. Zhang N, Zhu XH, Lei H, Ugurbil K,
Chen W. Simplified methods for calculat-
ing cerebral metabolic rate of oxygen based
on
17
O magnetic resonance spectroscopic
imaging measurement during a short
MRI.
Proc
Natl
Acad
Sci
U
S
A
1998;95(22):12934-12939.
76. Reddy R, Stolpen AH, Leigh JS. Detection of
17
ObyprotonT
1
rho dispersion imaging. J
Magn Reson B 1995;108(3):276-279.
77. Chen W, Zhu XH, Ugurbil K. Imaging cere-
bral metabolic rate of oxygen consumption
(CMRO
2
)using
17
O NMR approach at
ultra-high field. In: Shulman RG, Rothman
DL, editors. Brain Energetics and Neuronal
Activity. New York: John Wiley & Sons Ltd;
2004. p 125-146.
78. Arai T, Mori K, Nakao S, Watanabe K, Kito
K, Aoki M, Mori H, Morikawa S, Inubushi
T. In vivo oxygen-17 nuclear magnetic res-
onance for the estimation of cerebral blood
flow and oxygen consumption. Biochem Bio-
phys Res Commun 1991;179(2):954-961.
79. Fiat D, Kang S. Determination of the rate
of cerebral oxygen consumption and regional
cerebral blood flow by non-invasive
17
Oin
vivo NMR spectroscopy and magnetic res-
17
O
2
inhalation.
J
Cereb
Blood
Flow
Metab
2004;24(8):840-848.
88. Ter-Pogossian MM, Eichling JO, Davis DO,
Welch MJ. The measure in vivo of regional
cerebral oxygen utilization by means of oxy-
hemoglobin labeled with radioactive oxygen-
15. J Clin Invest 1970;49:381-391.
89. Lenzi GL, Jones T, Frackowiak RS. Positron
emission tomography: state of the art in neu-
rology. Prog Nucl Med 1981;7:118-137.
90. Mintun
MA,
Raichle
ME,
Martin
WR,
Herscovitch
P.
Brain
oxygen
utilization
